Incretin Biology and Therapeutics: Transforming Obesity and Associated Diseases

The conference connects basic and clinical research on incretin hormones with pharmaceutical development. Researchers examine mechanisms underlying metabolic treatments and emerging applications, discussing what remains unknown about GLP-1, GIP and approaches to obesity and associated diseases.